A European Medicines Agency (EMA) panel has recommended approval of a subcutaneous (under-the-skin) version of Sarclisa (isatuximab), an approved…
Articles by Marisa Wexler, MS
Adding Amplia Therapeutics‘ experimental drug narmafotinib to standard chemotherapy led to complete responses — meaning no detectable cancer on…
Most doctors who treat multiple myeloma expect that CAR T-cell therapies will soon became the standard first-line treatment,…
Tempus AI, a technology company focused on advancing precision medicine using artificial intelligence (AI), has announced a strategic collaboration…
Caris Life Sciences has launched a new diagnostic tool that aims to help guide treatment decisions for people with…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 to treat…
Researchers have developed a new cell therapy that aims to treat endometrial cancer by targeting cancer cells while also depleting…
Add-on treatment with mezigdomide significantly delayed cancer progression among people with hard-to-treat myeloma in a Phase 3 clinical trial,…
Sellas Life Sciences is seeking people with newly diagnosed acute myeloid leukemia (AML) for a clinical trial testing…
People with advanced pancreatic cancer who followed a ketogenic diet program administered by Virta Health while receiving chemotherapy…